tradingkey.logo
tradingkey.logo
Search

Foghorn Therapeutics Inc.

FHTX
Add to Watchlist
4.525USD
-0.215-4.54%
Close 07-31 16:00ETQuotes delayed by 15 min
265.66MMarket Cap
LossP/E TTM

Shareholding Stats

Updated: Mon, May 11
Updated: Mon, May 11
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Flagship Ventures
21.59%
Fidelity Management & Research Company LLC
9.19%
BVF Partners L.P.
9.03%
Eli Lilly and Company
6.81%
Deerfield Management Company, L.P.
6.22%
Other
47.17%
Shareholders
Shareholders
Proportion
Flagship Ventures
21.59%
Fidelity Management & Research Company LLC
9.19%
BVF Partners L.P.
9.03%
Eli Lilly and Company
6.81%
Deerfield Management Company, L.P.
6.22%
Other
47.17%
Shareholder Types
Shareholders
Proportion
Investment Advisor
22.50%
Venture Capital
21.61%
Hedge Fund
17.42%
Corporation
10.46%
Individual Investor
7.48%
Investment Advisor/Hedge Fund
6.19%
Research Firm
4.88%
Pension Fund
0.19%
Bank and Trust
0.10%
Other
9.16%

Institutional Shareholding

Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
190
42.73M
72.78%
-484.98K
2025Q4
164
41.10M
74.66%
--
2025Q3
169
41.10M
74.88%
-10.40K
2025Q2
170
41.10M
75.92%
+565.21K
2025Q1
173
40.55M
75.96%
-1.69M
2024Q4
167
40.40M
75.19%
+310.46K
2024Q3
173
40.09M
72.52%
+554.51K
2024Q2
167
39.52M
64.99%
+4.09M
2024Q1
168
26.53M
65.58%
-1.38M
2023Q4
166
26.27M
67.28%
-777.96K
View more

Shareholder Activity

Name
Shares Held
Proportion
Change
Chg %
Date
Flagship Ventures
12.67M
21.59%
--
--
Jan 13, 2026
Fidelity Management & Research Company LLC
5.40M
9.19%
-78.32K
-1.43%
Dec 31, 2025
BVF Partners L.P.
5.30M
9.03%
--
--
Dec 31, 2025
Eli Lilly and Company
4.00M
6.81%
--
--
Apr 23, 2025
Deerfield Management Company, L.P.
3.65M
6.22%
+393.70K
+12.09%
Dec 31, 2025
Kadoch (Cigall)
3.65M
6.22%
+28.53K
+0.79%
Apr 23, 2025
Raymond James & Associates, Inc.
2.51M
4.27%
+43.33K
+1.76%
Dec 31, 2025
The Klarman Family Foundation
2.14M
3.65%
--
--
Sep 30, 2024
BlackRock Institutional Trust Company, N.A.
2.13M
3.63%
+67.99K
+3.29%
Dec 31, 2025
Euclidean Capital, L.L.C.
1.57M
2.68%
--
--
Dec 31, 2025
View more

Related ETFs

Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
ProShares Ultra Nasdaq Biotechnology
0.03%
iShares Micro-Cap ETF
0.03%
Invesco Nasdaq Biotechnology ETF
0.02%
Global X Russell 2000 ETF
0.01%
ProShares Hedge Replication ETF
0.01%
iShares Biotechnology ETF
0.01%
ProShares UltraPro Russell2000
0.01%
iShares Russell 2000 Growth ETF
0.01%
Proshares Ultra Russell 2000
0.01%
Invesco Russell 2000 Dynamic Multifactor ETF
0%
View more
ProShares Ultra Nasdaq Biotechnology
Proportion0.03%
iShares Micro-Cap ETF
Proportion0.03%
Invesco Nasdaq Biotechnology ETF
Proportion0.02%
Global X Russell 2000 ETF
Proportion0.01%
ProShares Hedge Replication ETF
Proportion0.01%
iShares Biotechnology ETF
Proportion0.01%
ProShares UltraPro Russell2000
Proportion0.01%
iShares Russell 2000 Growth ETF
Proportion0.01%
Proshares Ultra Russell 2000
Proportion0.01%
Invesco Russell 2000 Dynamic Multifactor ETF
Proportion0%
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.